Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics  11, 438 - 440 (1995)
doi:10.1038/ng1295-438

Cardiac myosin binding protein−C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy

Gisèle Bonne1, Lucie Carrier1, Josiane Bercovici1, Corinne Cruaud2, Pascale Richard3, Bernard Hainque3, Mathias Gautel4, Siegfried Labeit4, Michael James5, Jacques Beckmann2, Jean Weissenbach2, Hans-Peter Vosberg6, Marc Fiszman1, Michel Komajda7 & Ketty Schwartz1

  1INSERM UR153, Pavillion Rambuteau, Groupe Hospitalier Pitié-Salpétrière, 47 Boulevard de L'Hôpital, F-75651 Paris Cedex 13, France

  2CNRS URA 1922, Généthon, Evry, France.

  3Service de Biochimie, Hôpital de la Salpétrière, Paris, France.

  4European Molecular Biology Laboratory, Heidelberg, Germany.

  5Nuffield Department of Clinical Medicine, The Wellcome Trust Centre for Human Genetics, Oxford, Great Britain.

  6Max-Planck Institut für Physiologische und Klinische Forschung, Bad Nauheim, Germany.

  7Service de Cardiologie, Hôpital de la Pitié-Salpétrière, Paris, France.

  *G.B. & L.C. contributed equally to the study.

 Correspondence should be addressed to K.S.

Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by a ventricular hypertrophy predominantly affecting the inter-ventricular septum and associated with a large extent of myocardial and myofibrillar disarray1. It is the most common cause of sudden death in the young. In the four disease loci found, three genes have been identified which code for beta-myosin heavy chain, cardiac tro-ponin T and alpha-tropomyosin2−7. Recently the human cardiac myosin binding protein-C (MyBP-C) gene was mapped to chromosome 11p11.2 (ref. 8), making this gene a good candidate for the fourth locus, CMH4 (ref. 5). Indeed, MyBP-C is a substantial component of the myofibrils that interacts with several proteins of the thick filament of the sarcomere9−13. In two unrelated French families linked to CMH4, we found a mutation in a splice acceptor site of the MyBP-C gene, which causes the skipping of the associated exon and could produce truncated cardiac MyBP-Cs. Mutations in the cardiac MyBP-C gene likely cause chromosome 11-linked hypertrophic cardiomyopathy, further supporting the hypothesis that hypertrophic cardiomyopathy results from mutations in genes encoding contractile proteins.


REFERENCES
  1. Maron, B.J. et al. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts). New Engl. J. Med. 316, 780−789 (1987). | PubMed  | ISI | ChemPort |
  2. Jarcho, J.A. et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql. New Engl. J. Med. 321, 1372−1378 (1989). | PubMed  | ISI | ChemPort |
  3. Watkins, H. et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nature Genet. 3, 333−337 (1993). | PubMed  | ISI | ChemPort |
  4. Thierfelder, L. et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc. natn. Acad. Sci. U.S.A. 90, 6270−6274 (1993). | ChemPort |
  5. Carrier, L. et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature Genet. 4, 311−313 (1993). | PubMed  | ISI | ChemPort |
  6. Geisterfer-Lowrance, A.A.T. et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62, 999−1006 (1990). | Article | PubMed  | ChemPort |
  7. Thierfelder, L. et al. alpha-troppmyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77, 701−712 (1994). | Article | PubMed  | ISI |
  8. Gautel, M., Zuffardi, O., Freiburg, A. & Labeit, S. Phospnorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J. 14, 1952−1960 (1995). | PubMed  | ISI | ChemPort |
  9. Offer, G., Moos, C. & Starr, R. A new protein of the thick filaments of vertebrate skeletal myofibrils. J. molec. Biol. 74, 653−676 (1973). | PubMed  | ISI | ChemPort |
  10. Starr, R. & Offer, G. The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem. J. 171, 813−616 (1978). | PubMed  | ISI | ChemPort |
  11. Moos, C., Mason, C.M., Besterman, J.M., Feng, I.N.M. & Dubin, J.H. The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. J. molec. Biol. 124, 571−586 (1978). | PubMed  | ISI | ChemPort |
  12. Yamamoto, K. & Moos, C., The C-proteins of rabbit red, white, and cardiac muscles. J. biol. Chem. 258, 8395−8401 (1983). | PubMed  | ISI | ChemPort |
  13. Fürst, D.O., Vinkemeyer, U. & Weber, K. Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length cDNA. J. Cell Sci. 102, 769−778 (1992). | PubMed  | ISI |
  14. James, M.R. et al. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nature Genet. 8, 70−76 (1994). | Article | PubMed  | ISI | ChemPort |
  15. Einheber, S. & Fischman, D. Isolation and characterization of a cDNA clone encoding avian skeletal muscle C-protein: an intracellular member of the immunoglobulin superfamily. Proc. natn. Acad. Sci. U.S.A. 87, 2157−2161 (1990). | ChemPort |
  16. Okagaki, T. et al. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J. Cell Biol. 123, 619−626 (1993). | Article | PubMed  | ISI | ChemPort |
  17. Koretz, J.F., Coluccio, L.M. & Bertasso, A.M. The aggregation characteristics of column-purified rabbit skeletal myosin in the presence and absence of C-protein at pH 7.0. Biophys. J. 37, 433−440 (1982). | PubMed  | ISI | ChemPort |
  18. Moos, C. & Feng, I.N.M. Effect of C-Protein on actomyosin ATPase. Biochem. biophys. Acta 632, 141−149 (1980). | Article | PubMed  | ChemPort |
  19. Hofmann, P.A., Hartzell, H.C. & Moss, R.L. Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J. gen. Physiol. 97, 1141−1163 (1991). | Article | PubMed  | ISI | ChemPort |
  20. Granzier, H.L. & Irving, T.C. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys. J. 68, 1027−1044 (1995). | PubMed  | ISI | ChemPort |
  21. de Tombe, P. & ter Keurs, H. An internal viscous element limits unloaded velocity of sarcomere shortening in rat myocardium. J. Physiol. 454, 619−642 (1992). | PubMed  | ChemPort |
  22. Sweitzer, N. & Moss, R. Determinants of loaded shortening velocity in single cardiac myocytes permeabilized with alpha-hemolysin. Circulation Res. 73, 1150−1162 (1993). | PubMed  | ISI | ChemPort |
  23. Hartzell, H.C. & Titus, L. Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. J. biol. Chem. 257, 2111−2120 (1982). | PubMed  | ISI | ChemPort |
  24. Schwartz, K. et al. Exclusion of myosin heavy chain and cardiac actin gene involvement in hypertrophic cardiomyopathies of several French families. Circulation Res. 71, 3−8 (1992). | PubMed  | ISI | ChemPort |
  25. Weissenbach, J. et al. A second generation linkage map of the human genome. Nature 359, 794−801 (1992). | Article | PubMed  | ISI | ChemPort |
  26. Vignal, A. Nonradioactive multiplex procedure for genotyping of microsatellite markers in Methods in Molecular Genetics: Chromosome and Gene Analysis 1 (ed. K.W. Adolph), 211−221 (Academic Press, Oriando, Florida, 1993). | ChemPort |
  27. Don, R.H., Cox, P.T., Wainwright, B.J., Baker, K. & Mattick, J.S. Touchdown PCR to circumvent spurious priming during gene amplification. Nucl. Acids Res. 19, 4008 (1991). | PubMed  | ISI | ChemPort |
  28. Ott, J. Linkage analysis and family classification under heterogeneity. Ann. hum. Genet. 47, 311−320 (1983). | PubMed  | ISI |
  29. Bonne, G., Carrier, L., Komajda, M. & Schwartz, K. The COX8 gene is not the disease gene of the CMH4 locus in Familial Hypertrophic Cardiomyopathy. J. med. Genet. 32, 670−671 (1995). | PubMed  | ISI | ChemPort |
 Top
 Top
References
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1995 Nature Publishing Group | Privacy policy